FDA Clears StatStrip for Capillary Testing with Critically Ill Patients
Nova Biomedical’s device is the only glucose meter cleared by FDA for use with critically ill patients.
Read MorePosted by Steve Halasey | Jan 10, 2019 | Culture Media |
Nova Biomedical’s device is the only glucose meter cleared by FDA for use with critically ill patients.
Read MorePosted by Steve Halasey | Jan 10, 2019 | Immunoassay, Point-of-Care |
Prompt POC testing is key for improving patient treatment.
Read MorePosted by Steve Halasey | Dec 12, 2018 | Compliance, Urinalysis & Toxicology |
The smartphone-based system supports home-use urinalysis testing, increasing consumer access to albumin:creatinine ratio testing.
Read MorePosted by Steve Halasey | Dec 4, 2018 | Research |
Preliminary study findings suggest that a point-of-care test currently under development has accuracy similar to a high-sensitivity troponin test, permitting early rule-out of a heart attack.
Read MorePosted by Steve Halasey | Nov 15, 2018 | Disease States, Infectious Diseases, Molecular Diagnostics, Sexually Transmitted Diseases |
Advanced testing methods promise improved patient outcomes and better protection of public health—with potential cost savings.
Read More